Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Ahong Huang"'
Autor:
Jashin J. Wu, Manish Patel, Feng Zeng, Ahong Huang, Xing Pan, Yiwen Cao, Naijun Chen, Huzefa Photowala, Vishvas Garg, Jeff Crowley
Publikováno v:
Journal of Dermatological Treatment, Vol 34, Iss 1 (2023)
Aim To compare real-world dose escalation of risankizumab with other US Food and Drug Administration (FDA)-approved biologic treatments for management of moderate-to-severe psoriasis (PsO) in the United States. Methods The Merative® MarketScan® Res
Externí odkaz:
https://doaj.org/article/a9d47e3c0a2d49c78d55c475b09339ae
Publikováno v:
AIDS Research and Therapy, Vol 17, Iss 1, Pp 1-12 (2020)
Abstract Background Once-daily, single-tablet regimens (STRs) have been associated with improved patient outcomes compared to multi-tablet regimens (MTRs). This study evaluated real world adherence and persistence of HIV antiretroviral therapy (ART),
Externí odkaz:
https://doaj.org/article/2ebce7ce03734835bfa1808dee6209a9
Autor:
Charmi Patel, MPH, RN, Antoine El Khoury, PhD, MS, Ahong Huang, MD, Li Wang, PhD, MS, MBA, Richa Bashyal, MPH
Publikováno v:
Current Therapeutic Research, Vol 92, Iss , Pp 100587- (2020)
Background: Schizophrenia is associated with high health care resource utilization and treatment costs. Objective: This study compared treatment patterns, health care resource utilization, and medical costs before and after a switch from oral antipsy
Externí odkaz:
https://doaj.org/article/b48bed938a9047d1813105bc7c98ba76
Autor:
April W Armstrong, Ahong Huang, Li Wang, Raymond Miao, Miraj Y Patel, Abhijit Gadkari, Usha G Mallya, Jingdong Chao
Publikováno v:
PLoS ONE, Vol 14, Iss 1, p e0210517 (2019)
At the time of this study, prior to the introduction of biologics in the US, systemic therapies used for the treatment of moderate-to-severe atopic dermatitis included off-label immunosuppressants and corticosteroids. Immunosuppressant therapy is ass
Externí odkaz:
https://doaj.org/article/60530dbd20c94b2797e1c2c246099422
Autor:
David Schapiro, Rattan Juneja, Ahong Huang, Alexandra Meeks, Dongju Liu, Felicia T. Gelsey, Magaly Perez-Nieves
Publikováno v:
Diabetes Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::62a1f8ca3f7740e9571de1bbd72f5a9a
https://doi.org/10.1007/s13300-023-01414-4
https://doi.org/10.1007/s13300-023-01414-4
Autor:
Stephen J. Freedland, Krishnan Ramaswamy, Ahong Huang, Rickard Sandin, Jack Mardekian, Neil M. Schultz, Nora Janjan, Daniel J. George
Publikováno v:
Clinical Genitourinary Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a36e39fb5f965db2a094b708561291c7
https://doi.org/10.1016/j.clgc.2023.01.003
https://doi.org/10.1016/j.clgc.2023.01.003
Publikováno v:
Neuropsychiatric Disease and Treatment
Purpose Compared to once-monthly paliperidone palmitate (PP1M), once-every-3-months paliperidone palmitate (PP3M) reportedly increases treatment adherence. The objective of this study was to compare treatment patterns, utilization, and costs among Ve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f50774af5232e4082f466c9b1e3d947
http://europepmc.org/articles/PMC8541768
http://europepmc.org/articles/PMC8541768
Autor:
Daniel J George, Krishnan Ramaswamy, Ahong Huang, David Russell, Neil M Schultz, Nora Janjan, Stephen J Freedland
Publikováno v:
Future oncology (London, England).
What is this summary about? This is a summary of a research article originally published in Prostate Cancer and Prostatic Diseases. There were few Black men in the clinical trials that led to the approval of the medications abiraterone and enzalutami
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8faacdeba5c359223dc8254aaf994448
https://pubmed.ncbi.nlm.nih.gov/34732856
https://pubmed.ncbi.nlm.nih.gov/34732856
Autor:
Freedland, Stephen J., Ramaswamy, Krishnan, Ahong Huang, Sandin, Rickard, Mardekian, Jack, Schultz, Neil M., Janjan, Nora, George, Daniel J.
Publikováno v:
Clinical Genitourinary Cancer; Aug2023, Vol. 21 Issue 4, p419-429, 11p
Autor:
DAVID SCHAPIRO, ALEXANDRA MEEKS, DONGJU LIU, FELICIA GELSEY, RATTAN JUNEJA, MAGALY PEREZ-NIEVES, AHONG HUANG
Publikováno v:
Diabetes. 71
Background: In the past 5 years, type 2 diabetes practice guidelines have shifted to prioritize agents with cardiovascular (CV) and renal benefit. This study assessed whether real-world medication use has changed in line with these evolving guideline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::261d02eb19d8cda1131ac0c0915e46f0
https://doi.org/10.2337/db22-107-lb
https://doi.org/10.2337/db22-107-lb